Tibolone: a compound with tissue specific inhibitory effects on sulfatase (Q40774322)

23 September 2017

title

Tibolone: a compound with tissue specific inhibitory effects on sulfatase (English)

1 reference

23 September 2017

4

1 reference

23 September 2017

de Gooyer ME

1

1 reference

23 September 2017

Kleyn GT

2

1 reference

23 September 2017

Smits KC

3

1 reference

23 September 2017

Verheul HA

5

1 reference

23 September 2017

Kloosterboer HJ

6

1 reference

23 September 2017

publication date

1 October 2001

1 reference

Molecular and Cellular Endocrinology

23 September 2017

published in

1 reference

23 September 2017

volume

183

1 reference

23 September 2017

issue

1-2

1 reference

23 September 2017

page(s)

55-62

1 reference

A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

Human estrogen sulfotransferase (hEST1) activities and its mRNA in various breast cancer cell lines. Effect of the progestin, promegestone (R-5020)

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomy-induced bone loss in sexually mature rats

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

Steroid metabolizing enzymes associated with the microvillar membrane of human placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

Cancer of the breast: the past decade (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

Constitutive expression of the steroid sulfatase gene supports the growth of MCF-7 human breast cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

Effects of progestagens and Org OD14 in in vitro and in vivo tumor models

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD-14) and its metabolites on human endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

In situ steroid sulfatase activity in human epithelial carcinoma cells of vaginal, ovarian, and endometrial origin

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

Estrogen therapy and osteoporosis: principles & practice

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

Regulation of sulphotransferase expression in the endometrium during the menstrual cycle, by oral contraceptives and during early pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

Human endometrial 3 beta-hydroxysteroid dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestagenic activity ratios of a steroidal drug (Org OD 14)

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

Clinical profile of Org OD 14

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

The in vivo human metabolism of tibolone

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900606-2

7 January 2021

10.1016/S0303-7207(01)00606-2

Identifiers

DOI

1 reference

23 September 2017

1 reference